Related Experiment Video
Updated: Jun 6, 2026
07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
CSIE: cancer subtyping via inference and ensemble.
Dao Tran1, Yen Thi-Hai Pham2, Hung N Luu2
1Department of Industrial and Systems Engineering, Wayne State University, 4815 4th St, Detroit, MI 48201, United States.
Briefings in Bioinformatics
|June 4, 2026
Summary
Cancer subtyping is enhanced by CSIE, a novel framework inferring missing omics data from gene expression. This approach improves precision oncology by enabling robust cancer subtype discovery even with incomplete multi-omics profiles.
Area of Science:
- Computational Biology
- Bioinformatics
- Genomics
Background:
- Multi-omics integration is crucial for precision oncology but hindered by incomplete data.
- Cost and technical issues often limit studies to single-omics data.
Purpose of the Study:
- Introduce CSIE (cancer subtyping via inference and ensemble), a framework to infer missing omics data.
- Enable accurate cancer subtyping using gene expression data and ensemble clustering.
Main Methods:
- A transformer-based inference module uses systems-level knowledge to predict missing omics layers.
- An ensemble clustering module integrates multi-omics data using diverse similarity metrics and algorithms.
Main Results:
- CSIE significantly outperforms 12 state-of-the-art methods across 66 cancer datasets.
- The framework demonstrates superior performance in scenarios with incomplete omics data.
- Validated on over 15,000 patients and 22 data modalities/platforms.
Conclusions:
- CSIE offers a scalable solution for high-resolution cancer subtyping in clinical settings.
- Shifts paradigm from exhaustive data collection to leveraging biological intelligence for data completion.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...